| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1993) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | B01AC13 |
| UNII: | X85G7936GV |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Integrin alpha-IIb/beta-3 inhibitor | DailyMed |
| Primary Target | |
|---|---|
| integrin αIIbβ3 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Acute Disease | 3 | D000208 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 3 | D000072657 | ClinicalTrials |
| Brain Ischemia | 3 | D002545 | ClinicalTrials |
| Angina, Stable | 2 | D060050 | ClinicalTrials |
| Carotid Stenosis | 1 | D016893 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 143653-53-6 |
| ChEMBL | CHEMBL1201584 |
| FDA SRS | X85G7936GV |
| Guide to Pharmacology | 6584 |
CONTENTS